Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
COVID-19 Saliva Screening Test Potential Global Market Report 2025
Request Sample Buy Now
Global COVID-19 Saliva Screening Test Potential Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

COVID-19 Saliva Screening Test Potential Global Market Report 2025

By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations), By Technology (Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9), By Mode of Testing (Centralized Testing, Decentralized Testing) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

COVID-19 Saliva Screening Test Potential Market Overview

• COVID-19 Saliva Screening Test Potential market size has reached to $3.9 billion in 2024

• Expected to grow to $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%

• Growth Driver: The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market

• Market Trend: Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness

• North America was the largest region in 2024.

What Is Covered Under COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better.

The main locations of COVID-19 saliva screening test potential are travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories, and other locations. Travel stations are designated areas in transportation hubs where individuals can undergo COVID-19 saliva screening tests before embarking on journeys. The various technologies used are fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9 and various modes of testing include centralized testing and decentralized testing.

COVID-19 Saliva Screening Test Potential Market Size and growth rate 2025 to 2029: Graph

What Is The COVID-19 Saliva Screening Test Potential Market Size 2025 And Growth Rate?

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

What Is The COVID-19 Saliva Screening Test Potential Market Growth Forecast?

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of E-Commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The forecast of 8.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade barriers could limit U.S. diagnostic innovation by inflating prices of high-throughput saliva-based Polymerase Chain Reaction(PCR) components from Singapore and the Netherlands, resulting in slower mass testing rollouts and higher lab processing fees. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The COVID-19 Saliva Screening Test Potential Market Segmented?

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

3) By Mode Of Testing: Centralized Testing, Decentralized Testing

Subsegments:

1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports

2) By Sports Arenas: Stadiums, Arenas, Event Halls

3) By Entertainment Venues: Theaters, Concert Halls, amusement parks, Nightclubs

4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks

5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas

6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites

7) By Other Locations: Healthcare Facilities, government buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues

What Is Driving The COVID-19 Saliva Screening Test Potential Market? The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market

The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in 2022, according to the Office for National Statistics, a UK-based national statistics organization on the epilepsy, UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting a nominal increase of 0.7% compared to spending in 2021. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential industry.

Who Are The Major Players In The Global COVID-19 Saliva Screening Test Potential Market?

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

What Are The Key Trends Of The Global COVID-19 Saliva Screening Test Potential Market? Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness

Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative technologies such as data-sharing platforms to enhance real-time communication and collaboration among healthcare providers, laboratories, and public health authorities, ultimately improving the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable the secure exchange of data among various stakeholders, such as healthcare providers, researchers, and organizations. They facilitate collaboration and information access to improve decision-making, efficiency, and outcomes across sectors. For instance, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center focuses on improving strategies for public health emergency response, ensuring that healthcare systems can effectively handle large-scale crises such as pandemics or natural disasters. It aims to enhance the capacity of the Mount Sinai Health System and collaborate with local, regional, and federal partners to develop comprehensive preparedness plans.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market? Hologic, Inc. Acquires Endomagnetics Ltd. To Strengthen Women's Health Solutions

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. With this acquisition, Hologic, Inc. aims to enhance its portfolio of innovative healthcare solutions and expand its market presence in the women's health sector. Endomagnetics Ltd. is a UK-based medical technology company that manufactures medical devices that help detect cancerous lymph nodes during surgery.

What Is The Regional Outlook For The Global COVID-19 Saliva Screening Test Potential Market?

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the COVID-19 Saliva Screening Test Potential Market?

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the COVID-19 Saliva Screening Test Potential Industry?

The covid-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 saliva screening test potential industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

COVID-19 Saliva Screening Test Potential Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.28 billion
Revenue Forecast In 2034 $6.03 billion
Growth Rate CAGR of 8.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing Subsegments: 1) By Travel Stations: Airports, Train Stations, Bus Stations, Seaports
2) By Sports Arenas: Stadiums, Arenas, Event Halls
3) By Entertainment Venues: Theaters, Concert Halls, Amusement Parks, Nightclubs
4) By Corporate Campus Environments: Offices, Corporate Campuses, Business Parks
5) By Universities And Colleges: Higher Education Campuses, Research Institutions, Student Housing Areas 6) By Factories: Manufacturing Plants, Production Facilities, Industrial Sites 7) By Other Locations: Healthcare Facilities, Government Buildings, Public Transportation Hubs, Shopping Centers, Other Public Or Private Venues
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential market Characteristics

3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

5.1. Global COVID-19 Saliva Screening Test Potential PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global COVID-19 Saliva Screening Test Potential market Growth Rate Analysis

5.4. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global COVID-19 Saliva Screening Test Potential Total Addressable Market (TAM)

6. COVID-19 Saliva Screening Test Potential market Segmentation

6.1. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Travel Stations

Sports Arenas

Entertainment Venues

Corporate Campus Environments

Universities And Colleges

Factories

Other Locations

6.2. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fluorescence-Labelled Antigen

RT-PCR

CRISPR-Cas9

6.3. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Centralized Testing

Decentralized Testing

6.4. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Airports

Train Stations

Bus Stations

Seaports

6.5. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stadiums

Arenas

Event Halls

6.6. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Theaters

Concert Halls

Amusement Parks

Nightclubs

6.7. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Offices

Corporate Campuses

Business Parks

6.8. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Higher Education Campuses

Research Institutions

Student Housing Areas

6.9. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Manufacturing Plants

Production Facilities

Industrial Sites

6.10. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healthcare Facilities

Government Buildings

Public Transportation Hubs

Shopping Centers

Other Public Or Private Venues

7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

7.1. Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Saliva Screening Test Potential market

9.1. China COVID-19 Saliva Screening Test Potential market Overview

9.2. China COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Saliva Screening Test Potential market

10.1. India COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Saliva Screening Test Potential market

11.1. Japan COVID-19 Saliva Screening Test Potential market Overview

11.2. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Saliva Screening Test Potential market

12.1. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Saliva Screening Test Potential market

13.1. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Saliva Screening Test Potential market

14.1. South Korea COVID-19 Saliva Screening Test Potential market Overview

14.2. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Saliva Screening Test Potential market

15.1. Western Europe COVID-19 Saliva Screening Test Potential market Overview

15.2. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Saliva Screening Test Potential market

16.1. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Saliva Screening Test Potential market

17.1. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Saliva Screening Test Potential market

18.1. France COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Saliva Screening Test Potential market

19.1. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Saliva Screening Test Potential market

20.1. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Saliva Screening Test Potential market

21.1. Eastern Europe COVID-19 Saliva Screening Test Potential market Overview

21.2. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Saliva Screening Test Potential market

22.1. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Saliva Screening Test Potential market

23.1. North America COVID-19 Saliva Screening Test Potential market Overview

23.2. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Saliva Screening Test Potential market

24.1. USA COVID-19 Saliva Screening Test Potential market Overview

24.2. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Saliva Screening Test Potential market

25.1. Canada COVID-19 Saliva Screening Test Potential market Overview

25.2. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Saliva Screening Test Potential market

26.1. South America COVID-19 Saliva Screening Test Potential market Overview

26.2. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Saliva Screening Test Potential market

27.1. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Saliva Screening Test Potential market

28.1. Middle East COVID-19 Saliva Screening Test Potential market Overview

28.2. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Saliva Screening Test Potential market

29.1. Africa COVID-19 Saliva Screening Test Potential market Overview

29.2. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

30.1. COVID-19 Saliva Screening Test Potential market Competitive Landscape

30.2. COVID-19 Saliva Screening Test Potential market Company Profiles

30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

31.1. University of North Carolina at Chapel Hill

31.2. Hologic Inc.

31.3. Beaumont Health

31.4. PerkinElmer Inc.

31.5. Quidel Corporation

31.6. University of Illinois at Urbana-Champaign

31.7. Cepheid

31.8. Seegene Inc.

31.9. ARUP Laboratories

31.10. Vatic Health Limited

31.11. Ambry Genetics Corporation

31.12. LumiraDx Ltd.

31.13. Yale School of Public Health

31.14. Gravity Diagnostics

31.15. Psomagen Inc.

32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

35.1 COVID-19 Saliva Screening Test Potential market In 2029 - Countries Offering Most New Opportunities

35.2 COVID-19 Saliva Screening Test Potential market In 2029 - Segments Offering Most New Opportunities

35.3 COVID-19 Saliva Screening Test Potential market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Roche Diagnostics Corporation Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Abbott Laboratories Financial Performance
  • Table 84: Becton Dickinson and Company Financial Performance
  • Table 85: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Roche Diagnostics Corporation Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Abbott Laboratories Financial Performance
  • Figure 84: Becton Dickinson and Company Financial Performance
  • Figure 85: Danaher Corporation Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Endoscopy Devices And Equipment Market 2023 – By Product (Endoscope, Endoscopy Operative Devices, Endoscopy Visualization Systems), By Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuro-endosco...

View Report

Musical Instruments Global Market Report 2025 – By Type (Stringed, Brass And Woodwind, Percussion, Keyboard), By Distribution Channel (Supermarkets\ Hypermarkets, Specialty Stores, Online Sales Channel), By Application (...

View Report

Lithium Global Market Report 2025 – By Type (Glass/Ceramics, Greases / Lubricants, Chemical Synthesis, Portable Electronics & Other Handhelds, Hybrids, Battery Electric Vehicle (bevy), Grid, and Other Power Storage Appli...

View Report

Automotive Noise, Vibration And Harshness Materials Global Market Report 2025 – By Type (Rubber, Plastic And Foam, Fibers, Other Types), By Vehicle (Passenger Cars, Light Commercial Vehicles (LCV), Heavy Commercial Vehic...

View Report

Spinal Imaging Global Market Report 2025 – By Product (X-Ray, CT, MRI, Ultrasound), By Application (Spinal Infection, Vertebral Fractures, Spinal Cancer, Spinal Cord and Nerve Compressions, Other Applications), By End-Us...

View Report

Healthcare Chatbots Global Market Report 2025 – By Component (Software, Services), By Deployment Model (On-Premise Model, Cloud-Based Model), By Application (Symptoms Check, Appointment Scheduling And Monitoring, Medical...

View Report

Birch Water Global Market Report 2025 – By Nature (Conventional, Organic), By Flavor (Strawberry, Rose Chip, Bilberry, Apple Ginger, Others), By Distribution Channel (Online Retailing, Store Based Retailing), By Applicat...

View Report

Frequently Asked Questions

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better. For further insights on this market, request a sample here

The market major growth driver - The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market. For further insights on this market, request a sample here

The covid-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.28 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment. The covid-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to " $6.03 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships. For further insights on this market, request a sample here

The covid-19 saliva screening test potentialmarket covered in this report is segmented –
1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing; Decentralized Testing Subsegments:
1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
2) By Sports Arenas: Stadiums; Arenas; Event Halls
3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues For further insights on this market, request a sample here

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Data Sharing Platforms Enhancing COVID-19 Saliva Screening And Public Health Preparedness. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global COVID-19 Saliva Screening Test Potential Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top